Intercure (INCR) vs Telomir Pharmaceuticals (TELO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Intercure (INCR) has outperformed Telomir Pharmaceuticals (TELO) over the past year, losing 36.5% versus a loss of 37.8%. Telomir Pharmaceuticals is the larger company by market cap ($82.5 million vs $77.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INCR | TELO |
|---|---|---|
| Share price | $5.13 | $1.12 |
| Market cap | $76.97M | $82.45M |
| 1-day change | 0.00% | 0.00% |
| YTD return | +12.75% | -15.79% |
| 1-year return | -36.47% | -37.78% |
| 5-year return | -85.53% | — |
| EPS (TTM) | $-0.95 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.45 | $2.09 |
| 52-week low | $3.40 | $0.888 |
| Distance from 52-week high | -39.29% | -46.44% |
| Average volume | 21.69K | 97.37K |
| Shares outstanding | 15.00M | 73.62M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
INCR vs TELO FAQ
Which is bigger, Intercure or Telomir Pharmaceuticals?
Telomir Pharmaceuticals (TELO) is larger, with a market capitalization of $82.45M compared with $76.97M for Intercure (INCR).
Which stock has performed better over the past year, INCR or TELO?
INCR returned -36.47% over the past 12 months, compared with -37.78% for TELO (price return, excluding dividends). Past performance does not predict future results.
Are Intercure and Telomir Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.